Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
Status:
Recruiting
Trial end date:
2026-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of adjuvant HIPEC with Mitomycin C
after colectomy in the treatment of colorectal cancer patients at high risk of peritoneal
carcinomatosis.
Phase:
Phase 3
Details
Lead Sponsor:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Collaborators:
Beijing Cancer Hospital Beijing Hospital Cancer Institute and Hospital, Chinese Academy of Medical Sciences Chongqing University Cancer Hospital First Affiliated Hospital of Chongqing Medical University First Affiliated Hospital, Sun Yat-Sen University First People's Hospital of Foshan Fudan University Guangdong Provincial Hospital of Traditional Chinese Medicine Guangdong Provincial People's Hospital Hebei Medical University Fourth Hospital Jiangmen Central Hospital Meizhou People's Hospital Nanfang Hospital of Southern Medical University Peking University People's Hospital People's Hospital of Deyang City People's Hospital of Guangxi People’s Hospital of Deyang City Renmin Hospital of Wuhan University Second Affiliated Hospital, School of Medicine, Zhejiang University Shantou Central Hospital Shenzhen Second People's Hospital Sichuan Provincial People's Hospital Sixth Affiliated Hospital, Sun Yat-sen University Sun Yat-sen University The Affiliated Hospital Of Southwest Medical University The Affiliated Hospital of Xuzhou Medical University The Affiliated Tumor Hospital of Guangxi Medical University The First Affiliated Hospital of Nanchang University The People's Hospital of Leshan The Second Affiliated Hospital of Chongqing Medical University The Third People's Hospital of Chengdu West China Hospital Wuhan Union Hospital, China Wuhan University Zhongshan People's Hospital, Guangdong, China ZhuHai Hospital